Chemical Structure (Jelmyto 01)
Jelmyto Kit
Product Images NDC 72493-103
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 33 technical images submitted to the FDA as part of the official labeling for Jelmyto (NDC 72493-103). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Urogen Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (Jelmyto 02)
Image (Jelmyto 03)
Image (Jelmyto 04)
Image (Jelmyto 05)
The text describes a package that contains three Vial Adaptors and three Syringe Adaptor HF under the brand name TEVADAPTOR®. It also includes a Luer lock connector and a Chilling Block made by UroGen Pharma.*
Image (Jelmyto 06)
Image (Jelmyto 07)
Image (Jelmyto 08)
Image (Jelmyto 09)
Image (Jelmyto 10)
Image (Jelmyto 11)
Image (Jelmyto 12)
Image (Jelmyto 13)
Image (Jelmyto 14)
Image (Jelmyto 15)
Image (Jelmyto 16)
Image (Jelmyto 17)
Image (Jelmyto 18)
Image (Jelmyto 19)
Image (Jelmyto 20)
Image (Jelmyto 21)
Image (Jelmyto 22)
Image (Jelmyto 23)
Image (Jelmyto 24)
Image (Jelmyto 25)
Image (Jelmyto 26)
Image (Jelmyto 27)
Image (Jelmyto 28)
Image (Jelmyto 29)
Principal Display Panel (Kit Carton)
Principal Display Panel (40 mg Vial Label)
A/ Jelmyto is a single-dose carton for pyelocalyceal use only. It contains 350-tonis. It is a warning that it is forbidden to use this product for any other purposes. The product is named as Jelmyto' and contains ritomycin. The product should be handled carefully and should be used as per the instructions provided on the package. There are certain instructions regarding the storage of the product available on the carton.*
Principal Display Panel (20 mL Vial Label)
MOCTHEOR T single-dose vial is a sterile solution of Jelmyto, which contains 40 mg of mitomycin used for pyelocalyceal treatment. Before use, the powder must be mixed with sterile hydrogel. The product should be stored between 20°C and 25°C. Each vial contains 40mg of mitomycin and 80 mg of mannitol. The usual dosage should be determined in accordance with the prescribing information. The product is distributed by UroGen Pharma Inc. in Princeton, NJ.*
Jelmyto 33
This is a single-dose vial containing 0.004 g hydroxypropyl and sterile hydrogel methcsose. It also contains 0.1 g poloamer and is intended for use in the preparation of JELMYTO™ 021 polyethylene glycol. It is not for direct administration and is distributed by UroGen Pharma. The instructions on how to prepare the solution can be found in the pharmacy's instructions. It should be stored between 20°C and 25°C, with excursions permitted between 15°C and 30°C. Excessive heat above 40°C should be avoided. The vial is intended for use with mitomycin for pyelocalyceal solution. The lot and Bp numbers are provided.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
